We are live on
!
Find out more
BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
16 hedge funds and large institutions have $3.11M invested in Better Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
74% more call options, than puts
Call options by funds: $647K | Put options by funds: $372K
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
12% more capital invested
Capital invested by funds: $2.77M → $3.11M (+$345K)
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
2
Calls
$647K
Puts
$372K
Net Calls
+$275K
Net Calls Change
-$120K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$184K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.2K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$27.4K |
| 4 |
Millennium Management
New York
|
+$26K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$20.2K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$147K |
| 2 |
Two Sigma Investments
New York
|
-$100K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$23K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.1K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$18 |
